CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+0.02%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.24B
AUM Growth
+$1.24B
(+4.1%)
Cap. Flow
+$83.6M
Cap. Flow
% of AUM
6.73%
Top 10 Holdings %
Top 10 Hldgs %
54.28%
Holding
49
New
12
Increased
9
Reduced
7
Closed
8
Top Buys
| 1 |
AstraZeneca
AZN
|
$79.6M |
| 2 |
NUVA
NuVasive, Inc.
NUVA
|
$52.1M |
| 3 |
Cigna
CI
|
$48.6M |
| 4 |
Dentsply Sirona
XRAY
|
$25.8M |
| 5 |
Perrigo
PRGO
|
$22.7M |
Top Sells
| 1 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$55.7M |
| 2 |
AbbVie
ABBV
|
$43.9M |
| 3 |
Bruker
BRKR
|
$36.9M |
| 4 |
CONMED
CNMD
|
$33.9M |
| 5 |
Masimo
MASI
|
$31M |
Sector Composition
| 1 | Healthcare | 78.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $103M | 7.04% | 1,750,000 +100,000 | +6% | +$5.91M |
|
|
2
AstraZeneca
AZN
$248B
| $79.6M | 5.42% | +1,250,000 | New | +$79.6M |
|
|
3
Masimo
MASI
$7.59B
| $73.6M | 5.01% | 1,900,000 -800,000 | -30% | -$31M |
|
|
MDCO
4
DELISTED
Medicines Co
MDCO
| $71.5M | 4.87% | 2,500,000 | – | – |
|
|
ESRX
5
DELISTED
Express Scripts Holding Company
ESRX
| $66.7M | 4.54% | 750,000 +50,000 | +7% | +$4.45M |
|
|
CYBX
6
DELISTED
CYBERONICS INC
CYBX
| $59.5M | 4.05% | 1,000,000 +250,000 | +33% | +$14.9M |
|
|
GHDX
7
DELISTED
Genomic Health, Inc.
GHDX
| $58.4M | 3.97% | 2,100,000 | – | – |
|
8
Select Medical
SEM
$1.61B
| $56.7M | 3.86% | 3,500,000 +500,000 | +17% | +$8.1M |
|
|
UAM
9
DELISTED
Universal American Corp
UAM
| $53M | 3.61% | 5,234,898 | – | – |
|
|
NUVA
10
DELISTED
NuVasive, Inc.
NUVA
| $52.1M | 3.55% | +1,100,000 | New | +$52.1M |
|
11
Orthofix Medical
OFIX
$592M
| $49.7M | 3.38% | 1,500,000 | – | – |
|
|
12
Cigna
CI
$80.3B
| $48.6M | 3.31% | +300,000 | New | +$48.6M |
|
13
Labcorp
LH
$23.1B
| $48.5M | 3.3% | 400,000 | – | – |
|
|
ARIA
14
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $47.6M | 3.24% | 5,750,000 -1,250,000 | -18% | -$10.3M |
|
|
ARNA
15
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $34.8M | 2.37% | 7,500,000 | – | – |
|
|
SQNM
16
DELISTED
SEQUENOM INC NEW
SQNM
| $27.4M | 1.86% | 9,000,000 | – | – |
|
|
17
Dentsply Sirona
XRAY
$2.85B
| $25.8M | 1.75% | +500,000 | New | +$25.8M |
|
|
AMRN
18
Amarin Corp
AMRN
$311M
| $24.6M | 1.67% | 10,000,000 -2,000,000 | -17% | -$4.92M |
|
|
19
Perrigo
PRGO
$3.27B
| $22.7M | 1.54% | +122,748 | New | +$22.7M |
|
|
KND
20
DELISTED
Kindred Healthcare
KND
| $22.3M | 1.52% | 1,100,000 -400,000 | -27% | -$8.12M |
|
21
Cross Country Healthcare
CCRN
$438M
| $18.9M | 1.29% | 1,493,765 +71,200 | +5% | +$903K |
|
22
Nektar Therapeutics
NKTR
$568M
| $18.8M | 1.28% | +1,500,000 | New | +$18.8M |
|
23
Quest Diagnostics
DGX
$20.3B
| $18.1M | 1.23% | +250,000 | New | +$18.1M |
|
24
Option Care Health
OPCH
$4.65B
| $16.9M | 1.15% | 4,650,000 +1,650,000 | +55% | +$5.99M |
|
25
Protalix BioTherapeutics
PLX
$124M
| $14.2M | 0.97% | +7,274,577 | New | +$14.2M |
|